News & Insights
NAM: Don’t Disincentivize Biopharmaceutical Innovation
advocated against allowing such “march-in” rights and was instrumental in the administration’s decision not to finalize the previous administration’s draft guidance on the practice. (Manufacturers strongly urge the administration to rescind the guidance permanently.) The NAM also opposes “any proposal to impose a tax on the royalties that universities earn from licensing patented discoveries made …
Manufacturers: Bipartisan DOMINANCE Act Will Counter China’s Grip on Critical Minerals
Washington, D.C. – Following House passage of the bipartisan Developing Overseas Mineral Investments and New Allied Networks for Critical Energies (DOMINANCE) Act, National Association of Manufacturers President and CEO Jay Timmons released the following statement: “China’s dominance of critical mineral supply chains poses a growing threat to America’s manufacturing competitiveness, economic security and technological leadership—at …
